Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab.
Gemma Bruera
No relevant relationships to disclose
Katia Cannita
No relevant relationships to disclose
Alessandra Tessitore
No relevant relationships to disclose
Alessio Cortellini
No relevant relationships to disclose
Jean Christophe Sabourin
No relevant relationships to disclose
Mario Tosi
No relevant relationships to disclose
Thierry Frébourg
No relevant relationships to disclose
Edoardo Alesse
No relevant relationships to disclose
Corrado Ficorella
No relevant relationships to disclose
Enrico Ricevuto
No relevant relationships to disclose